Skip to main content
X

Explore the Journal of Critical Limb Ischemia (JCLI), a quarterly international peer-reviewed journal and online clinical resource for those treating chronic limb threatening ischemia.

Recently Published

Original Contribution

The shift in health care services from hospital-based to community- and home-based care, often provided by family members, exacts a significant emotional and physical toll on both patients and caregivers, an experience known as caregiver fatigue, caregiver strain, or caregiver burden. The Zarit Burden Interview (ZBI) and the Short Form Zarit Burden Interview (ZBI-12) were used to assess caregiver burden in 10 patients with lower extremity amputation who presented with a caretaker over a 3-month period.

Editorial/Commentary
Videos

Watch as Barry T. Katzen, MD, FACR, FACC, FSIR, president and founding board member of the Critical Limb Ischemia Global Society, discusses why you should join the Society. 

At the 2024 SIR Meeting in Salt Lake City, Utah, interventional radiologist Mark Lessne, MD, from Vascular & Interventional Specialists, Charlotte Radiology in Charlotte, North Carolina, presented several sessions, including “Beyond Paclitaxel: A Review of Non-Paclitaxel-Based Antiproliferative Therapies for PAD Management.” We spoke with Dr. Lessne about his presentation and the future of PAD management.

At the 2024 SIR Meeting in Salt Lake City, Utah, Waseem Wahood, MD, MS, from HCA Florida Aventura Hospital, Aventura, Florida, presented results from a study that analyzed 30-day perioperative outcomes from the National Surgical Quality Improvement Project (NSQIP) in patients who received intervention for chronic limb-threatening ischemia (CLTI). We spoke with Dr. Wahood about his study and what the results could mean for patients with CLTI.

Videos

Watch as Dr. Thomas Zeller reviews his presentation on the treatment of symptomatic femoropopliteal disease with drug-coated balloons vs bare-metal stents, which he gave at the Amputation Prevention Symposium in August 2023. 

Stay in the know

JCLI Newsletter